JoelleLau

Partner-in-Charge Hong Kong

香港 + 852.3189.7384

Joelle Lau, Partner-in-Charge of the Hong Kong Office, has nearly 20 years of experience including taking a lead advisory role on some of the most significant listings on the Hong Kong Stock Exchange. She has advised clients across a range of corporate finance, fund formation, private equity, and M&A transactions.

Joelle's extensive experience on Hong Kong Stock Exchange listings includes: advising the underwriters on the listings of China Zheshang Bank, Precision Tsugami (China) Corporation Limited, and Hanhua Financial Holdings Ltd and advising the issuers on the listings of Evergreen Products Group Limited and Tsaker Chemical Group Limited.

Prior to joining Jones Day she advised the international underwriters on the US$22.1 billion Agricultural Bank of China IPO, which remains one of the largest IPOs to date. Joelle advises on ongoing compliance matters for numerous listed issuers based in the PRC. She also assists various private funds, corporate groups, state-owned enterprises, and private companies in their day-to-day legal and compliance matters.

Joelle has practiced in New York, Hong Kong, and Singapore, and her private equity and private M&A experience spans these three jurisdictions. She assists investment funds in their formation and downstream investment work (including PIPEs). Joelle most recently advised AGIC Capital in their fund formation and their investments in Italy, Germany, and the United States.

Joelle also acts for offerors and financial advisors in public M&A transactions. Recent experience includes the mandatory takeover transactions in HK by Foxconn (Far East) Limited and Fung Tung Limited as offerors.

担当案件

  • Affiliate of Centre Lane Partners acquires appliance business from Instant BrandsJones Day advised an affiliate of Centre Lane Partners in the acquisition and financing of the appliances business of Instant Brands, designer and distributor of kitchen and home appliances, including the Instant Pot, pursuant to Section 363 of title 11 of the United States Code.
  • Junshi Biosciences forms joint venture with Rxilient Biotech to develop and commercialize toripalimab in Southeast AsiaJones Day advised Junshi Biosciences in the formation of a joint venture company, Excellmab, with Rxilient Biotech to develop and commercialize toripalimab, an anti-PD-1 monoclonal antibody drug, in nine Southeast Asian countries.
  • AGIC Capital closes $1.2 billion fund for investments in smart industriesJones Day acted as fund formation counsel to AGIC Capital for its $1.2 billion final closing of its second fund, AGIC Fund II L.P., which will be focused on advanced industrial and medical technology investments.
  • AGIC Capital sells Fotona to Vitruvian Partners LLPJones Day advised AGIC Capital ("AGIC") as Dutch counsel on the sale of Fotona, a leading medical laser focused EBD company, to the international equity firm Vitruvian Partners LLP.
  • Shanghai Junshi Biosciences completes $329 million placing of new H Shares on main board of The Stock Exchange of Hong Kong LimitedJones Day advised Shanghai Junshi Biosciences Co., Ltd. (the “Company”), a company listed on the main board of The Stock Exchange of Hong Kong Limited and the STAR Market of the Shanghai Stock Exchange, in connection with its US$329 million placing of new H Shares of the Company.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Swissport completes cross-border restructuringJones Day has advised sponsor, HNA, on the cross-border restructuring of the air freight and logistics business, Swissport.
  • OMERS completes US$490 million acquisition of shares in ESR Cayman LimitedJones Day advised OMERS Administration Corporation, the pension plan for Ontario's municipal employees, in connection with its US$490 million acquisition of Equity Shares in Hong Kong listed ESR Cayman Limited ("ESR"), a leading pan-Asia logistics real estate platform, from an affiliate of Warburg Pincus.
  • Junshi and Revitope team up for TEAC molecules through development, license, and equityJones Day represented Shanghai Junshi Biosciences Co., Ltd. in a research collaboration and license agreement with Revitope Oncology Inc. and its subsidiary to collaborate in the research and development of T-cell engaging cancer immunotherapies that utilize Junshi's antibody technology platform with Revitope's proprietary dual-antigen targeting technology platform.
  • Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirusJones Day represented Shanghai Junshi Biosciences Co., Ltd. in its strategic collaboration and license agreement with Eli Lilly and Company for the development, manufacturing, and commercialization of two antibodies for the prevention and treatment of the COVID-19 SARS-CoV-2 novel coronavirus.
  • AGIC Capital acquires majority stake in Farsound for £115 millionJones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), a European-Asian private equity fund focused on investments in high quality industrial and medical companies, in its acquisition of a majority stake in Farsound Limited and its subsidiaries, a leading provider of technology enabled supply chain solutions, from its current owner Rubicon Partners at a total enterprise value of £115 million.
  • Wipro acquires Splash CorporationJones Day advised Wipro Enterprises Private Ltd. (Wipro) in its acquisition of Splash Corporation, a leading personal care products player in the Philippines, from Ang Hortaleza Corporation.
  • Cabot sells its Specialty Fluids business to Sinomine (Hong Kong) Rare Metals Resources Co. Limited for $135 millionJones Day advised Cabot Corporation in the sale of its Specialty Fluids Business to Sinomine (Hong Kong) Rare Metals Resources Co. Limited, a wholly owned subsidiary of Sinomine Resource Group Co., Ltd., for $135 million.
  • CLSA Capital, CLSA, CCB International Capital, and China Galaxy complete approximate $210 million IPO on The Stock Exchange of Hong Kong Limited by Luzhou BankJones Day acted as counsel for the sole sponsor, CLSA Capital Markets Limited, and underwriters, comprising of CLSA Limited, CCB International Capital Limited, China Galaxy International Securities (Hong Kong) Co., Limited, and others, in connection with the $210 million initial public offering of H shares on The Stock Exchange of Hong Kong Limited by Luzhou Bank Co., Ltd. and concurrent Regulation S offering.
  • Shanghai Junshi Biosciences completes $450 million IPO on The Stock Exchange of Hong Kong LimitedJones Day acted as Hong Kong and U.S. counsel for Shanghai Junshi Biosciences Co., Ltd. in connection with its over $450 million initial public offering on The Stock Exchange of Hong Kong Limited and concurrent Rule 144A and Regulation S offerings.
  • Midas acquires Microlife CorporationJones Day advised Midas Fund LP, a joint venture partner in Midas Company Limited, in the acquisition by Midas Company of all of the issued and outstanding shares of Microlife Corporation by way of a 100 percent share swap, for the aggregate consideration of NT$9.3 billion (US$300.9 million).
  • AGIC Capital sells Gimatic Srl to Barnes Group for €370 million (US$432.2 million)Jones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), a leading European-Asian private equity firm focused on equity investments in controlling interests and qualified minorities, in connection with its sale of Gimatic Srl to Barnes Group Inc. for €370 million (US$432.2 million) in cash.
  • AGIC Capital sells minority stake in CNCE Global Holdings (Hong Kong) Co., LimitedJones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), an Asian-European private equity investor focused on industrial technology companies in the European and North American mid-market, in connection with its sale of minority stake in CNCE Global Holdings (Hong Kong) Co., Limited.
  • AGIC Capital acquires Fotona from The Gores GroupJones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), an Asian-European private equity investor focused on industrial technology companies in the European and North American mid-market, in connection with the acquisition and related financing of Fotona, a U.S. and Slovenia based developer of high-tech laser systems and components, primarily used in medicine, aesthetics, surgery, gynecology, and dentistry, from private equity firm, The Gores Group.
  • Halcyon Capital, BOCI Asia, Hong Kong Asset Management, and Halcyon Securities complete IPO on Main Board of Hong Kong Stock Exchange of Precision Tsugami (China) Corporation LimitedJones Day advised Halcyon Capital Limited, as sole sponsor, and BOCI Asia, Hong Kong Asset Management, and Halcyon Securities, as underwriters, in connection with the initial public offering and listing on the Main Board of the Hong Kong Stock Exchange (HKSE) of Precision Tsugami (China) Corporation Limited, an established CNC high precision machine tool manufacturer in China.